{"id":13019,"date":"2025-02-10T22:10:02","date_gmt":"2025-02-10T22:10:02","guid":{"rendered":"https:\/\/bofillmir.cl\/?p=13019"},"modified":"2026-02-16T22:30:23","modified_gmt":"2026-02-16T22:30:23","slug":"what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations","status":"publish","type":"post","link":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/","title":{"rendered":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Partner <a href=\"https:\/\/www.linkedin.com\/in\/andrea-abascal-59142a32\/\"><\/a>Andrea Abascal and associate <a href=\"https:\/\/www.linkedin.com\/in\/andr%C3%A9s-sep%C3%BAlveda-31ab161a2\/\"><\/a>Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring access. Proper regulation would not only improve availability but also help reduce the significant cost borne by the State, as many patients have resorted to legal action to obtain treatment, ultimately forcing the government to cover the expenses.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Full article here: https:\/\/www.ibanet.org\/orphan-drugs-chile<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1-1024x1024.webp\" alt=\"\" class=\"wp-image-13021\" srcset=\"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1-1024x1024.webp 1024w, https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1-300x300.webp 300w, https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1-150x150.webp 150w, https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1-768x768.webp 768w, https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1-12x12.webp 12w, https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp 1080w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Partner Andrea Abascal and associate Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":13021,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-13019","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-bm"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Partner Andrea Abascal and associate Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"nmedina@bofillmir.cl\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Bofill Mir Abogados - Santiago, Chile\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados\" \/>\n\t\t<meta property=\"og:description\" content=\"Partner Andrea Abascal and associate Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-02-10T22:10:02+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-02-16T22:30:23+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Partner Andrea Abascal and associate Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#blogposting\",\"name\":\"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados\",\"headline\":\"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations\",\"author\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/author\\\/nmedinabofillmir-cl\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/bofillmir.cl\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/AmCham-1.webp\",\"width\":1080,\"height\":1080},\"datePublished\":\"2025-02-10T22:10:02+00:00\",\"dateModified\":\"2026-02-16T22:30:23+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#webpage\"},\"articleSection\":\"Noticias BM\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng#listItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/bofillmir.cl\\\/eng\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/category\\\/noticias-bm\\\/#listItem\",\"name\":\"Noticias BM\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/category\\\/noticias-bm\\\/#listItem\",\"position\":2,\"name\":\"Noticias BM\",\"item\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/category\\\/noticias-bm\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#listItem\",\"name\":\"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng#listItem\",\"name\":\"Inicio\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#listItem\",\"position\":3,\"name\":\"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/category\\\/noticias-bm\\\/#listItem\",\"name\":\"Noticias BM\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/#organization\",\"name\":\"Boofill Mir\",\"description\":\"Santiago, Chile\",\"url\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/author\\\/nmedinabofillmir-cl\\\/#author\",\"url\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/author\\\/nmedinabofillmir-cl\\\/\",\"name\":\"nmedina@bofillmir.cl\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/74a09b1359364a63932648557809db58e7b2dc305b355121d797c4efd385feda?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"nmedina@bofillmir.cl\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#webpage\",\"url\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/\",\"name\":\"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados\",\"description\":\"Partner Andrea Abascal and associate Andr\\u00e9s Sep\\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/author\\\/nmedinabofillmir-cl\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/author\\\/nmedinabofillmir-cl\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/bofillmir.cl\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/AmCham-1.webp\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#mainImage\",\"width\":1080,\"height\":1080},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\\\/#mainImage\"},\"datePublished\":\"2025-02-10T22:10:02+00:00\",\"dateModified\":\"2026-02-16T22:30:23+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/#website\",\"url\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/\",\"name\":\"Boofill Mir\",\"description\":\"Santiago, Chile\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/bofillmir.cl\\\/eng\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados","description":"Partner Andrea Abascal and associate Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring","canonical_url":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#blogposting","name":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados","headline":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations","author":{"@id":"https:\/\/bofillmir.cl\/eng\/author\/nmedinabofillmir-cl\/#author"},"publisher":{"@id":"https:\/\/bofillmir.cl\/eng\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp","width":1080,"height":1080},"datePublished":"2025-02-10T22:10:02+00:00","dateModified":"2026-02-16T22:30:23+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#webpage"},"isPartOf":{"@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#webpage"},"articleSection":"Noticias BM"},{"@type":"BreadcrumbList","@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/bofillmir.cl\/eng#listItem","position":1,"name":"Inicio","item":"https:\/\/bofillmir.cl\/eng","nextItem":{"@type":"ListItem","@id":"https:\/\/bofillmir.cl\/eng\/category\/noticias-bm\/#listItem","name":"Noticias BM"}},{"@type":"ListItem","@id":"https:\/\/bofillmir.cl\/eng\/category\/noticias-bm\/#listItem","position":2,"name":"Noticias BM","item":"https:\/\/bofillmir.cl\/eng\/category\/noticias-bm\/","nextItem":{"@type":"ListItem","@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#listItem","name":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations"},"previousItem":{"@type":"ListItem","@id":"https:\/\/bofillmir.cl\/eng#listItem","name":"Inicio"}},{"@type":"ListItem","@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#listItem","position":3,"name":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations","previousItem":{"@type":"ListItem","@id":"https:\/\/bofillmir.cl\/eng\/category\/noticias-bm\/#listItem","name":"Noticias BM"}}]},{"@type":"Organization","@id":"https:\/\/bofillmir.cl\/eng\/#organization","name":"Boofill Mir","description":"Santiago, Chile","url":"https:\/\/bofillmir.cl\/eng\/"},{"@type":"Person","@id":"https:\/\/bofillmir.cl\/eng\/author\/nmedinabofillmir-cl\/#author","url":"https:\/\/bofillmir.cl\/eng\/author\/nmedinabofillmir-cl\/","name":"nmedina@bofillmir.cl","image":{"@type":"ImageObject","@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/74a09b1359364a63932648557809db58e7b2dc305b355121d797c4efd385feda?s=96&d=mm&r=g","width":96,"height":96,"caption":"nmedina@bofillmir.cl"}},{"@type":"WebPage","@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#webpage","url":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/","name":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados","description":"Partner Andrea Abascal and associate Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/bofillmir.cl\/eng\/#website"},"breadcrumb":{"@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#breadcrumblist"},"author":{"@id":"https:\/\/bofillmir.cl\/eng\/author\/nmedinabofillmir-cl\/#author"},"creator":{"@id":"https:\/\/bofillmir.cl\/eng\/author\/nmedinabofillmir-cl\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp","@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#mainImage","width":1080,"height":1080},"primaryImageOfPage":{"@id":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/#mainImage"},"datePublished":"2025-02-10T22:10:02+00:00","dateModified":"2026-02-16T22:30:23+00:00"},{"@type":"WebSite","@id":"https:\/\/bofillmir.cl\/eng\/#website","url":"https:\/\/bofillmir.cl\/eng\/","name":"Boofill Mir","description":"Santiago, Chile","inLanguage":"en-US","publisher":{"@id":"https:\/\/bofillmir.cl\/eng\/#organization"}}]},"og:locale":"en_US","og:site_name":"Bofill Mir Abogados - Santiago, Chile","og:type":"article","og:title":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados","og:description":"Partner Andrea Abascal and associate Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring","og:url":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/","og:image":"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp","og:image:secure_url":"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp","og:image:width":1080,"og:image:height":1080,"article:published_time":"2025-02-10T22:10:02+00:00","article:modified_time":"2026-02-16T22:30:23+00:00","twitter:card":"summary_large_image","twitter:title":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations - Bofill Mir Abogados","twitter:description":"Partner Andrea Abascal and associate Andr\u00e9s Sep\u00falveda, from our Life Sciences practice, published this article for the International Bar Association, analyzing access to orphan drugs in markets like Chile. Despite progress in local research, clinical trial, and the emergence of and orphan drug registry, the lack of comprehensive regulation remains the main obstacle to ensuring","twitter:image":"https:\/\/bofillmir.cl\/wp-content\/uploads\/2025\/07\/AmCham-1.webp"},"aioseo_meta_data":{"post_id":"13019","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2025-07-17 22:10:04","updated":"2026-02-16 23:09:18","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/bofillmir.cl\/eng\" title=\"Inicio\">Inicio<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/bofillmir.cl\/eng\/category\/noticias-bm\/\" title=\"Noticias BM\">Noticias BM<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tWhat we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Inicio","link":"https:\/\/bofillmir.cl\/eng"},{"label":"Noticias BM","link":"https:\/\/bofillmir.cl\/eng\/category\/noticias-bm\/"},{"label":"What we talk when we talk about orphan drugs in Chile: access, research and sanitary registrations","link":"https:\/\/bofillmir.cl\/eng\/what-we-talk-when-we-talk-about-orphan-drugs-in-chile-access-research-and-sanitary-registrations\/"}],"_links":{"self":[{"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/posts\/13019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/comments?post=13019"}],"version-history":[{"count":1,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/posts\/13019\/revisions"}],"predecessor-version":[{"id":13022,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/posts\/13019\/revisions\/13022"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/media\/13021"}],"wp:attachment":[{"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/media?parent=13019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/categories?post=13019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bofillmir.cl\/eng\/wp-json\/wp\/v2\/tags?post=13019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}